Wednesday, September 30, 2020 4:28:21 AM
The original plan was to develop, test and bring to market the extracorporeal treatment. In cooperation with ASU the development of a diagnostic tool was added and only days ago they announced the joint production of a preventative COVID-19 nasal spray. It's taking time but recent developments will take Halberd to the next level. My expectation is they will come up with new partners, probably a pharmaceutical company (existing producer of nasal sprays).
https://www.otcmarkets.com/filing/html?id=14147939&guid=tcj6UekP1eDse8h
https://halberdcorporation.com/wp-content/uploads/2020/09/ASU-K-Fully-Executed.pdf
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM